Inventor · disambiguated record
Ken Yamada
Also filed as: YAMADA KEN · YAMADA KEN-ICHI
17 granted patents·19 pending applications·13 citations·filing 2006–2025
89Inventor score
Top patents by PatentIndex Score
36 records- 0192US11827882B2Modified oligonucleotides targeting SNPsUNIV MASSACHUSETTS·Filed 2019·Granted Nov 28, 2023·7 cites·20 claims
- 0284US12077758B2Oligonucleotides for SARS-CoV-2 modulationUNIV MASSACHUSETTS·Filed 2021·Granted Sep 3, 2024·2 cites·18 claims
- 0383US12024706B2Modified oligonucleotides targeting SNPsUNIV MASSACHUSETTS·Filed 2020·Granted Jul 2, 2024·1 cites·20 claims
- 0479US10844055B2Naphthyridinone derivatives and their use in the treatment of arrhythmiaNOVARTIS AG·Filed 2019·Granted Nov 24, 2020·1 cites·15 claims
- 0579US2024066132A1Novel fatty acids and their use in conjugation to biomoleculesNOVARTIS AG·Filed 2023·Application pending·0 cites
- 0678US11820985B2Modified oligonucleotides with increased stabilityUNIV MASSACHUSETTS·Filed 2020·Granted Nov 21, 2023·1 cites·44 claims
- 0777US11519893B2Therapeutic drug for lipid-peroxidation-induced diseases and screening method for therapeutic drugs for lipid-peroxidation-induced diseasesYAMADA KEN ICHI·Filed 2018·Granted Dec 6, 2022·1 cites·4 claims
- 0876US12306164B2Therapeutic drug for lipid-peroxidation-induced diseases and screening method for therapeutic drugs for lipid-peroxidation-induced diseasesYAMADA KEN ICHI·Filed 2022·Granted May 20, 2025·0 cites·8 claims
- 0976US2024327836A1MODIFIED OLIGONUCLEOTIDES TARGETING SNPsUNIV MASSACHUSETTS·Filed 2024·Application pending·0 cites
- 1073US2024336916A1Synthesis of modified oligonucleotides with increased stabilityUNIV MASSACHUSETTS·Filed 2024·Application pending·0 cites
- 1173US2023324359A1Therapeutic drug for lipid-peroxidation-induced diseases and screening method for therapeutic drugs for lipid-peroxidation-induced diseasesYAMADA KEN ICHI·Filed 2023·Application pending·0 cites
- 1271US2024132888A1MODIFIED OLIGONUCLEOTIDES TARGETING SNPsUNIV MASSACHUSETTS·Filed 2023·Application pending·0 cites
- 1371US2024141362A1Modified oligonucleotides with increased stabilityUNIV MASSACHUSETTS·Filed 2023·Application pending·0 cites
- 1471US2024309372A1Stabilization of oligonucleotide and oligonucleotide-protein complex using alkylated phosphateUNIV MASSACHUSETTS·Filed 2024·Application pending·0 cites
- 1568US2024425860A1OLIGONUCLEOTIDES FOR SARS-CoV-2 MODULATIONUNIV MASSACHUSETTS·Filed 2024·Application pending·0 cites
- 1667US11530213B2Naphthyridinone derivatives and their use in the treatment of arrhythmiaNOVARTIS AG·Filed 2020·Granted Dec 20, 2022·0 cites·16 claims
- 1767US2024167029A1Modified guide rnas for crispr genome editingUNIV MASSACHUSETTS·Filed 2023·Application pending·0 cites
- 1865US12146136B2Synthesis of modified oligonucleotides with increased stabilityUNIV MASSACHUSETTS·Filed 2021·Granted Nov 19, 2024·0 cites·17 claims
- 1965US2025066780A1Oligonucleotides with internucleotide linkage modifications for kidney targetingUNIV MASSACHUSETTS·Filed 2024·Application pending·0 cites
- 2065US2025059539A1Sglt-2 targeting oligonucleotidesUNIV MASSACHUSETTS·Filed 2024·Application pending·0 cites
- 2164US2024293555A1Carbohydrate conjugates for the delivery of therapeutic oligonucleotidesUNIV MASSACHUSETTS·Filed 2023·Application pending·0 cites
- 2261US10266531B2Naphthyridinone derivatives and their use in the treatment of arrhythmiaNOVARTIS AG·Filed 2017·Granted Apr 23, 2019·0 cites·23 claims
- 2360US8193349B24-benzylamino-1-carboxylacyl-piperidine derivatives as CETP inhibitorsMOGI MUNETO·Filed 2008·Granted Jun 5, 2012·0 cites·6 claims
- 2455US2021388348A1Modified guide rnas for crispr genome editingUNIV MASSACHUSETTS·Filed 2021·Application pending·0 cites
- 2554US8440682B24-benzylamino-1-carboxylacyl-piperidine derivatives as CETP inhibitorsMOGI MUNETO·Filed 2012·Granted May 14, 2013·0 cites·3 claims
- 2652US8420641B2Method of inhibiting CETP activity with 4-benzylamino-1-carboxylacyl-piperidine derivativesMOGI MUNETO·Filed 2012·Granted Apr 16, 2013·0 cites·6 claims
- 2747US8759365B2Organic compoundsMOGI MUNETO·Filed 2008·Granted Jun 24, 2014·0 cites·12 claims
- 2845US11725002B2Detection reagents and kit for identifying oxidized state and glycated state of low-density lipoproteinsFUSO PHARMACEUTICAL IND·Filed 2018·Granted Aug 15, 2023·0 cites·9 claims
- 2945US2022023283A1Pharmaceutical composition for treatment of dementia and cerebrovascular disordersYAMADA KEN ICHI·Filed 2020·Application pending·0 cites
- 3044US2025313839A1Conjugates for tissue-specific oligonucleotide deliveryUNIV MASSACHUSETTS·Filed 2025·Application pending·0 cites
- 3144US2022096410A1Pharmaceutical composition for intraocular or oral administration for treatment of retinal diseasesYAMADA KEN ICHI·Filed 2020·Application pending·0 cites
- 3243US2009075968A1CETP inhibitorsSAKAKI JUNICHI·Filed 2006·Application pending·0 cites
- 3343US2009286790A1Organic compoundsIMASE HIDETOMO·Filed 2007·Application pending·0 cites
- 3442US2018153861A1Method of treating atherosclerosis in high triglyceride subjectsNOVARTIS AG·Filed 2017·Application pending·0 cites
- 3540US9867811B2Method of treating atherosclerosis in high triglyceride subjectsARAI YOSHIE·Filed 2012·Granted Jan 16, 2018·0 cites·12 claims
- 3639US11609238B2Method for detecting a radical compound derived from a lipid and a compound derived from the radical compoundYAMADA KEN ICHI·Filed 2018·Granted Mar 21, 2023·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Ken Yamada files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →